Antiretroviral‐Induced Toxicity in Umbilical Cord Blood‐Derived Haematopoietic Stem/Progenitor Cells
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Candice Laverne Hendricks und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Faculty of Health Sciences, Institute for Cellular and Molecular Medicine, University of Pretoria, Pretoria, South Africa. Hauptthemen laut MEDLINE: Fetal Blood, Hematopoietic Stem Cells, Anti-Retroviral Agents. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute for Cellular and Molecular Medicine, University of Pretoria, South African Medical Research Council.
Abstract (Originalsprache)
Improvements in administration and efficacy of antiretroviral therapy (ART) have reduced rates of mother‐to‐child transmission (MTCT) of human immunodeficiency virus (HIV) to < 2%. However, in utero exposure to antiretrovirals (ARVs) leads to abnormalities in HIV‐exposed uninfected (HEU) infants. We determined the effect of five ARVs on human umbilical cord blood (UCB)‐derived haematopoietic stem/progenitor cells (HSPC) with the aim of exploring a potential causal relationship with haematological abnormalities. Efavirenz (EFV) was cytotoxic to HSPCs alone and in combination with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC). Dolutegravir (DTG) had a biphasic effect on HSPC expansion. Immunophenotypic analysis showed increased erythroid and granulocyte precursors after 7‐day culture with these drugs. Finally, using colony forming unit (CFU) assays, we observed impairment in the formation of CFU‐GEMM and CFU/Burst forming unit (BFU) erythroid (E) in the presence of DTG, lamivudine (3TC) and TDF, both visually and immunophenotypically. We conclude that multiple potential HSPC toxicities exist with ARVs commonly used in pregnancy, prompting the need for further research to confirm the safety of these drugs in this vulnerable group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Faculty of Health Sciences, Institute for Cellular and Molecular Medicine, University of Pretoria, Pretoria, South Africa.
- SAMRC Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
- Department of Pharmacology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
- Beckman Coulter Life Sciences, Pretoria, South Africa.
ORCID-Profile: Candice Laverne Hendricks
Förderung
- Institute for Cellular and Molecular Medicine, University of Pretoria
- South African Medical Research Council
Zitieren
APA
Hendricks, C. L., Ellero, A., Mellet, J., Stivaktas, V., & Pepper, M. S. (2025). Antiretroviral‐Induced Toxicity in Umbilical Cord Blood‐Derived Haematopoietic Stem/Progenitor Cells. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70557
Vancouver
Hendricks CL, Ellero A, Mellet J, Stivaktas V, Pepper MS. Antiretroviral‐Induced Toxicity in Umbilical Cord Blood‐Derived Haematopoietic Stem/Progenitor Cells. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70557
BibTeX
@article{Hendricks2025,
author = {Hendricks, Candice Laverne and Ellero, Andrea and Mellet, Juanita and Stivaktas, Voula and Pepper, Michael Sean},
title = {Antiretroviral‐Induced Toxicity in Umbilical Cord Blood‐Derived Haematopoietic Stem/Progenitor Cells},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70557}
}
EUVIMED